ACA
GWPH

Avoro Capital Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Avoro Capital Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-133,600
Closed -$17.7M – 51
2016
Q3 		$17.7M Buy
+133,600
New +$12.8M 3.11% 14

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Avoro Capital Advisors's GWPH Position: Q4 2016 in Review

Avoro Capital Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2016, closing a stake of 133,600 shares — an estimated $17.7M sold.

Avoro Capital Advisors first reported a position in GWPH in Q3 2016 and held it in 1 quarter. The position peaked at $17.7M in Q3 2016. 164 funds tracked by Wall St. Rank hold GWPH as of Q4 2016.

  • Avoro Capital Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2016 after selling out during the quarter.
  • Avoro Capital Advisors sold 133,600 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2016, an estimated $17.7M.
  • Avoro Capital Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2016 and held it in 1 quarter.
  • Avoro Capital Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $17.7M in Q3 2016.
  • 164 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2016.

Based on Avoro Capital Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.